U.S. Q2 GDP growth was revised up to 2.2%, surpassing expectations and the previous quarter's 2.1%, while inflation cooled with the core PCE index rising 0.2% in August, below forecasts. Personal spending also increased more than expected, signaling a healthy consumer base. These positive economic indicators boosted gold prices to session highs, reflecting renewed investor interest amid moderated inflation pressures. The data suggests a resilient economy that could influence Federal Reserve policy and market trends going forward.
Gold price movement is the subject, with Pluang market data providing context. For readers following US stocks, here is Pluang's market snapshot as of Sep 30, 2026 18:52 WIB: out of 150 US stocks, 78 rose and 57 fell. Notable movers include COIN at USD 192.30 (+1.20%), XPEV at USD 9.58 (+1.16%), and META at USD 730.43 (-1.15%).
Clean Harbors Co-CEO Gerstenberg has sold 2,500 shares of the company. Insider sales like this can indicate personal financial decisions or views on the company’s stock value. Investors often watch such moves for clues about company prospects, though...
A recent survey by Summer's Eve reveals that while 63% of U.S. women feel more comfortable discussing intimate health than five years ago, over half still avoid these conversations due to embarrassment. The research highlights a cultural shift toward...
Q32 Bio announced positive 36-week results from its Phase 2a SIGNAL-AA trial of bempikibart for severe alopecia areata, showing meaningful hair regrowth and durable responses even after 16 weeks off treatment. The drug demonstrated a favorable safety...
Lion Group Holding Ltd. sold all its Solana holdings and part of its Bitcoin on September 29, 2026, to buy around 38,102 additional Hyperliquid (HYPE) tokens, increasing its total HYPE holdings to about 232,900 tokens valued at $20.1 million. This mo...
Fulcrum Therapeutics announced the discontinuation of its pociredir program for sickle cell disease after the FDA raised serious concerns about cancer risks linked to the drug class. This followed findings of high rates of secondary blood cancers wit...
